[go: up one dir, main page]

EE03687B1 - Furandiarylmethylidene derivatives, method of their preparation and use in therapy - Google Patents

Furandiarylmethylidene derivatives, method of their preparation and use in therapy

Info

Publication number
EE03687B1
EE03687B1 EE9800333A EE9800333A EE03687B1 EE 03687 B1 EE03687 B1 EE 03687B1 EE 9800333 A EE9800333 A EE 9800333A EE 9800333 A EE9800333 A EE 9800333A EE 03687 B1 EE03687 B1 EE 03687B1
Authority
EE
Estonia
Prior art keywords
furandiarylmethylidene
therapy
derivatives
preparation
furandiarylmethylidene derivatives
Prior art date
Application number
EE9800333A
Other languages
Estonian (et)
Other versions
EE9800333A (en
Inventor
Nicolai Eric
Teulon Jean-Marie
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of EE9800333A publication Critical patent/EE9800333A/en
Publication of EE03687B1 publication Critical patent/EE03687B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
EE9800333A 1996-04-04 1997-04-03 Furandiarylmethylidene derivatives, method of their preparation and use in therapy EE03687B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9604236A FR2747123B1 (en) 1996-04-04 1996-04-04 NOVEL DIARYLMETHYLIDENE TETRAHYDROFURANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES
FR9607922A FR2747124B1 (en) 1996-04-04 1996-06-26 NOVEL FURANIC DIARYLMETHYLIDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES
PCT/FR1997/000602 WO1997037984A1 (en) 1996-04-04 1997-04-03 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof

Publications (2)

Publication Number Publication Date
EE9800333A EE9800333A (en) 1999-04-15
EE03687B1 true EE03687B1 (en) 2002-04-15

Family

ID=9490907

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800333A EE03687B1 (en) 1996-04-04 1997-04-03 Furandiarylmethylidene derivatives, method of their preparation and use in therapy

Country Status (28)

Country Link
EP (1) EP0891345B1 (en)
JP (1) JP2000508638A (en)
KR (1) KR20000005146A (en)
CN (1) CN1215396A (en)
AR (1) AR006539A1 (en)
AT (1) ATE204268T1 (en)
AU (1) AU717146B2 (en)
BG (1) BG62808B1 (en)
BR (1) BR9708510A (en)
CA (1) CA2248949A1 (en)
CZ (1) CZ318898A3 (en)
DE (1) DE69706157T2 (en)
DK (1) DK0891345T3 (en)
EE (1) EE03687B1 (en)
ES (1) ES2162678T3 (en)
FR (2) FR2747123B1 (en)
GE (1) GEP20032924B (en)
IL (1) IL126105A (en)
NO (1) NO984624L (en)
NZ (1) NZ331672A (en)
PL (1) PL329213A1 (en)
PT (1) PT891345E (en)
RU (1) RU2189979C2 (en)
SI (1) SI0891345T1 (en)
SK (1) SK283292B6 (en)
TW (1) TW353660B (en)
WO (1) WO1997037984A1 (en)
ZA (1) ZA972894B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
US6026814A (en) 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
WO1998043966A1 (en) * 1997-04-02 1998-10-08 Merck Frosst Canada & Co. Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
FR2775477B1 (en) * 1998-02-27 2000-05-19 Union Pharma Scient Appl NOVEL HETEROCYCLIC DIARYLMETHYLENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES
CN1106392C (en) * 2000-10-24 2003-04-23 中国科学院上海有机化学研究所 Butenolide containing no substituent at beta position and its synthesis process
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
EP1562930A4 (en) * 2002-11-05 2008-12-10 Magnachem Int Lab Inc Synthetic lactone formulations and method of use
CA2524568C (en) * 2003-03-31 2012-07-17 Council Of Scientific & Industrial Research Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
DE602004002832T2 (en) 2003-05-07 2007-06-06 Osteologix A/S TREATMENT OF CARTILAGE / BONE DISEASES WITH WATER-SOLUBLE STRONTIUM SALTS
US8779168B2 (en) * 2010-12-16 2014-07-15 Transitions Optical, Inc. Lactone compounds and materials made therefrom
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111288T3 (en) * 1993-01-15 1998-03-01 Searle & Co NEW 3,4-DIARYL THIOPHENES AND ANALOGS OF THE SAME USEFUL AS ANTI-INFLAMMATORY AGENTS.
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge

Also Published As

Publication number Publication date
FR2747124A1 (en) 1997-10-10
FR2747124B1 (en) 1998-06-26
GEP20032924B (en) 2003-03-25
SK283292B6 (en) 2003-05-02
AR006539A1 (en) 1999-09-08
EP0891345A1 (en) 1999-01-20
TW353660B (en) 1999-03-01
WO1997037984A1 (en) 1997-10-16
PL329213A1 (en) 1999-03-15
IL126105A (en) 2001-08-26
NO984624D0 (en) 1998-10-02
SK137598A3 (en) 1999-02-11
IL126105A0 (en) 1999-05-09
ATE204268T1 (en) 2001-09-15
BG102771A (en) 1999-06-30
DE69706157D1 (en) 2001-09-20
CN1215396A (en) 1999-04-28
DE69706157T2 (en) 2002-04-11
AU2393397A (en) 1997-10-29
NO984624L (en) 1998-11-30
BG62808B1 (en) 2000-08-31
CZ318898A3 (en) 1999-01-13
DK0891345T3 (en) 2001-12-03
JP2000508638A (en) 2000-07-11
RU2189979C2 (en) 2002-09-27
SI0891345T1 (en) 2002-02-28
ZA972894B (en) 1997-11-04
ES2162678T3 (en) 2002-01-01
PT891345E (en) 2002-02-28
EE9800333A (en) 1999-04-15
FR2747123A1 (en) 1997-10-10
KR20000005146A (en) 2000-01-25
NZ331672A (en) 2000-02-28
AU717146B2 (en) 2000-03-16
EP0891345B1 (en) 2001-08-16
BR9708510A (en) 1999-08-03
CA2248949A1 (en) 1997-10-16
FR2747123B1 (en) 1998-06-26

Similar Documents

Publication Publication Date Title
FI955235A7 (en) Oxazolidinion derivatives, their preparation and use
EE9800459A (en) Spiro-piperidine derivatives and their use as therapeutic agents
EE9600172A (en) Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments
EE9700039A (en) Spiro-azabicyclic compounds used in therapy and their preparation process
FI934220A7 (en) Piperidine derivatives, their preparation and their use in therapy
FI962927A7 (en) Tetracycline derivatives, preparation method and use
FI951468A7 (en) Lipopeptide derivatives, method for their preparation and use
EE9700145A (en) Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds
FI944600L (en) Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy
FI954763A7 (en) Auxin derivatives, their preparation and their therapeutic use
FI955906A7 (en) O6-substituted guanine derivatives, method for their preparation and their use in the treatment of tumor cells
EE9700288A (en) Azacycloalkane derivatives, their preparation and use in therapy
EE9900155A (en) 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, process for their preparation and use in therapy
PL327854A1 (en) Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents
FI931414A7 (en) Imidazole derivatives, method for their preparation and their use in therapy
FI951060A7 (en) Formulations and treatment methods
EE03687B1 (en) Furandiarylmethylidene derivatives, method of their preparation and use in therapy
EE04317B1 (en) 4-Oxo-3,5-dihydro-4H-pyridazino [4.5-b] indole-1-ethanamide derivatives, their preparation and their use in therapy
EE9900218A (en) 1,4-Diazabicyclo [2.2.2] oct-2-ylmethyl benzoate derivatives, their preparation and their use in therapy
EE9800451A (en) Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
EE9900414A (en) 2,3-dihydrofuro [3,2-b] pyridine derivatives, their preparation and use in therapy
EE9900135A (en) N- (2-benzothiazolyl) -1-piperidinethanamine derivatives, their preparation and their use in therapy
FI970750L (en) Indole-2,3-dione-3-oxime derivatives, their preparation and use
FI954141L (en) Oxazoloquinolone derivatives, their preparation and their use in therapy

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231